A report from Morgan Stanley reiterates its $7 price target and downgrades its rating to Underweight on DemandTec DMAN.
The report states, “Single-digit organic growth in FY12 implies risk to consensus FY13 estimates looking for revenue growth to reaccelerate to 13%, vs. us at 9%. DMAN trades at 22x EV/CY12e FCF, in line with companies growing 15%+, an unsupported level in our view."
DMAN closed yesterday at $8.36.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in